Stocks
Boston Scientific (BSX) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 304.0% | 217.3% | 216.2% | 176.8% | 176.8% | 157.9% | |||
| Changes by years, y/y, % | +49pp | -87pp | -1pp | -39pp | 0pp | -12.9% | |||
Boston Scientific. R&D/CAPEX, %
Boston Scientific. R&D/CAPEX, changes, pp
Boston Scientific (BSX) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| R&D/CAPEX, % | 172.8% | 136.0% | 136.0% | 149.4% | 247.1% | 157.9% | ||
| Changes by years, y/y, % | -24pp | -29pp | -29pp | -129pp | +73pp | |||
| Changes by quarters, q/q, % | -1pp | -37pp | 0pp | +13pp | +98pp | |||
